Cargando…
The efficacy and safety of varenicline alone versus in combination with nicotine lozenges for smoking cessation among hospitalised smokers (VANISH): study protocol for a randomised, placebo-controlled trial
INTRODUCTION: Smoking is a leading cause of premature deaths globally. The health benefits of smoking cessation are many. However, majority of quit attempts are unsuccessful. One way to potentially improve success rates is to evaluate new combinations of existing smoking cessation therapies that may...
Autores principales: | Gobarani, Rukshar Kaizerali, Abramson, Michael J, Bonevski, Billie, Weeks, Gregory R, Dooley, Michael J, Smith, Brian J, Veale, Antony, Webb, Ashley, Kirsa, Sue, Thomas, Dennis, Miller, Alistair, Gasser, Rudi, Paul, Eldho, Parkinson, Jacqueline, Meanger, Darshana, Coward, Lisa, Kopsaftis, Zoe, Rofe, Olivia, Lee, Paula, George, Johnson |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539569/ https://www.ncbi.nlm.nih.gov/pubmed/33028555 http://dx.doi.org/10.1136/bmjopen-2020-038184 |
Ejemplares similares
-
Quitting experiences and preferences for a future quit attempt: a study among inpatient smokers
por: Thomas, Dennis, et al.
Publicado: (2015) -
Development and validation of a 21-item challenges to stopping smoking (CSS-21) scale
por: Thomas, Dennis, et al.
Publicado: (2016) -
Does smoking cessation with varenicline worsen vascular endothelial function?
por: Umeda, Akira, et al.
Publicado: (2013) -
Perceived barriers to smoking cessation in selected vulnerable groups: a systematic review of the qualitative and quantitative literature
por: Twyman, Laura, et al.
Publicado: (2014) -
Characterising the use of varenicline: an analysis of the Australian dispensing claims data
por: Gobarani, Rukshar K., et al.
Publicado: (2022)